Status:
UNKNOWN
Metagenomic Next-Generation Sequencing for Diagnosis of Ascites Infection in End-stage Liver Diseases
Lead Sponsor:
Nanfang Hospital, Southern Medical University
Collaborating Sponsors:
Meng Chao Hepatobiliary Hospital of Fujian Medical University
The First Hospital of Jilin University
Conditions:
Ascites Infection
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Ascites is the most common complication of cirrhosis, and its development is associated with substantially increased mortality. Ascites infection including spontaneous bacterial peritonitis (SBP), bac...
Detailed Description
The study is divided into 2 parts: Firstly, the study will test 3 types of sample by means of mNGS, including ascites fluid, peritoneal dialysis fluid and postoperative drainage fluid and evaluate th...
Eligibility Criteria
Inclusion
- Hospitalization cirrhotic patients;
- Age \>18 years old;
- Paitents with ascites at hospital admission.
Exclusion
- Pregnant women;
- Hepatic tumor or extrahepatic related cancer;
- Identified secondary peritonitis;
- Ascites not related to portal hypertension;
- Not provide written consent.
Key Trial Info
Start Date :
August 12 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 28 2021
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04125654
Start Date
August 12 2019
End Date
February 28 2021
Last Update
August 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nanfang Hospital
Guangzhou, Guangdong, China, 510515